Sigachi Industries Limited (SIGACHI) fundamentals
Sigachi Industries Limited is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as SIGACHI (ISIN INE0D0K01022). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Sigachi Industries Limited does
Sigachi Industries Limited is an India-based pharmaceutical company. The Company is a manufacturer of microcrystalline cellulose (MCC) and cellulose-based excipients. It offers vitamin mineral nutrient blends, active pharmaceutical ingredients (APIs), and operations and maintenance (O&M) services. It delivers solutions such as HiCel and AceCel across various industries, including pharmaceutical, food and nutraceutical, chemical, and cosmetic. In the pharmaceutical industry, its products have applications in API, pre-formulated excipients, thickeners/ stabilizers, binders, super disintegrants, carriers, lubricants and nutraceutical formulations. In the food and nutraceutical industry, its products have applications in nutrition, ready-to-use additives, stabilizers and dietary fiber. In the cosmetic industry, its products have applications in skin care, hair care and toiletry. In the chemical industry, its cellulose products are used in electrodes and as filter aid.
Valuation and market data
| Last close | ₹37.93 |
|---|---|
| Market capitalisation | ₹1,297 crore |
| Enterprise value | ₹1,273 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.12 |
| Price to sales (TTM) | 2.72 |
| Book value per share | ₹17.92 |
| Dividend yield | 26.36% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Mon Nov 15 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹486 crore | ₹-88 crore | ₹-83 crore | 0.00 |
| Mar 2025 | ₹509 crore | ₹92 crore | ₹70 crore | 2.06 |
| Mar 2024 | ₹411 crore | ₹70 crore | ₹57 crore | 1.81 |
| Mar 2023 | ₹309 crore | ₹54 crore | ₹44 crore | 1.42 |
| Mar 2022 | ₹253 crore | ₹52 crore | ₹40 crore | 15.44 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 36.7% |
|---|---|
| Foreign institutions (FII) | 1.3% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 62.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.